monocrotaline has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Al-Omran, M; Bhatt, DL; Chowdhury, B; Connelly, KA; Hess, DA; Kabir, MG; Luu, AZ; Luu, VZ; Mazer, CD; Pan, Y; Quan, A; Sabongui, S; Teoh, H; Verma, S | 1 |
Furuichi, K; Hisada, Y; Iwata, Y; Kaneko, S; Kitagawa, K; Okumura, T; Shimizu, M; Wada, T; Yokoyama, H; Yoshimoto, K | 1 |
2 other study(ies) available for monocrotaline and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension.
Topics: Animals; Benzhydryl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Fibrosis; Glucosides; Heart Ventricles; Hemodynamics; Humans; Hypertrophy, Right Ventricular; Lung; Male; Models, Animal; Monocrotaline; Mortality; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats, Sprague-Dawley; Risk Assessment; Sodium-Glucose Transporter 2 Inhibitors; Vascular Remodeling | 2020 |
Matrix metalloproteinase-2 (MMP-2) and membrane-type 1 MMP (MT1-MMP) affect the remodeling of glomerulosclerosis in diabetic OLETF rats.
Topics: Albuminuria; Animals; Blotting, Western; Diabetes Complications; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Immunoenzyme Techniques; Male; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Monocrotaline; Rats; Rats, Inbred OLETF; Real-Time Polymerase Chain Reaction; RNA, Messenger | 2011 |